Table 3.
Clinical Comparisons between male and female Subjects
Characteristics | Male (N = 37) | Female (N = 54) | P-value |
---|---|---|---|
Mean age (years) | 11.8 ± 4.0 | 11.9 ± 3.9 | NS |
DM duration (years) | 4.5 ± 2.6 | 3.7 ± 2.7 | NS |
Pre-BMI z-score | 0.66 ± 0.88 | 0.58 ± 0.85 | NS |
Post-BMI z-score | 0.87 ± 0.71 | 0.74 ± 0.73 | NS |
Pre-Activity Level | 2.0 + 0.68 | 2.0 + 0.68 | NS |
Post-Activity Level | 2.1 + 0.70 | 2.2 + 0.67 | NS |
Pre-TDD (U/kg) | 0.82 ± 0.20 | 0.91 ± 0.26 | NS |
Post- TDD (U/kg) | 0.84 ± 0.20 | 0.87 ± 0.22 | NS |
Pre % Basal | 43.9 ± 12.6 | 44.1 ± 10.9 | NS |
Post % Basal | 39.1 ± 8.9 | 41.7 ± 9.2 | NS |
Pre-bolus:basal | 1.49 ± 0.82 | 1.43 ± 0.70 | NS |
Post-bolus:basal | 1.69 ± 0.65 | 1.53 ± 0.65 | NS |
Pre- HbA1c | 8.1 ± 0.8 | 8.2 ± 0.8 | NS |
Post- HbA1c | 7.6 ± 0.6† | 7.8 ± 0.7† | <0.01 |
Pre-FBG | 179.8 ± 39.9 | 183.2 ± 48.8 | NS |
Post-FBG | 162.5 ± 33.7† | 163.4 ± 31.7 | <0.05 |
Pre-hypo/2 week | 1.48 ± 0.75 | 1.99 ± 0.86 | <0.01 |
Post-hypo/2 week | 1.0 ± 0.4† | 1.53 ± 0.90† | <0.01 |
Data are mean ± SD. total daily dose (TDD), fasting blood glucose (FBG). Pre” values represent baseline data collected at the beginning of the study per group. “Post” values represent data collected after one year of insulin pump therapy
p- value, comparison between male vs. female
†p < 0.01, Comparison between pre and post characteristics